Massivemarkets

Nasdaq: ETRA · Listed Sep 18, 2026

Electra Therapeutics IPO

IPO price

$15.00

Electra Therapeutics (ETRA) priced its IPO at $15.00 a share and has traded on Nasdaq since Sep 18, 2026.

ETRA today$8.44-43.73%since IPO15-min delayed · as of 6:34:19 PM EST on Nov 18, 2026

See the ETRA quote

First trading day · Sep 18, 2026

VWAP 14.61first trade 15.00fell below the IPO price · 12:20high 15.39$13.51volume · rising bars above the line, falling bars below268.35K12:004:00
IPO price
$15.00
inside the range of $14 to $16
First trade
$15.00
+0.00% from the IPO price
First-day last trade
$13.51
-9.93% from the IPO price, regular session
Raise
$350M
before the underwriters' option

These numbers are from the first trading day, Sep 18, 2026.

How ETRA did against the market

ETRA against the market, from its first trade at 12:00 ET to the last trade of the session.

ETRA from its first trade
-9.93%
Against the market (QQQ)
-10.6 pts

ETRA fell 9.9% from its first trade to the last trade of the session. That is 10.6 points worse than the market.

Same-day moves do not show that ETRA caused them. The market is QQQ, the Nasdaq-100 ETF.

The debut race

ETRA against other big listings, as the percent change from each stock's own IPO price.

The first 30 trading days. Each point is the last regular-session trade of a day.

+100%+200%IPOday 1day 5day 10day 15day 20day 25day 30Figma '25 +69.64%Reddit '24 +40.32%CoreWeave '25 +28.42%Arm '23 -3.06%Klarna '25 -7.33%ETRA -42.47%

The IPO scoreboard

ETRA against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

ETRA against other big IPOs: the money raised, and the return from each IPO price at the first trade, at the last trade of day 1, and on day 5 and day 30.
IPORaisedFirst tradeDay 1 closeDay 1 close, as a barDay 5Day 30
Electra Therapeutics '26$350M+0.00%-9.93%-21.20%-42.47%
Figma '25$1.22B+157.58%+252.42%+173.64%+69.64%
Circle '25$1.05B+122.58%+168.45%+278.18%+622.98%
Reddit '24$748M+38.24%+47.97%+69.90%+40.32%
Arm '23$5.23B+10.00%+23.76%+3.63%-3.06%
Klarna '25$1.37B+30.00%+16.14%+13.73%-7.33%
CoreWeave '25$1.5B-2.50%+0.02%+34.32%+28.42%

Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.

The offering

The Electra Therapeutics IPO offers 23.33M shares to raise $350M, before any underwriters' option.

$12$14$15$16$18
Expected price range
$14 to $16
IPO price
$15.00
Shares offered
23.33M
Money raised
$350M
Listing date
Sep 18, 2026
Exchange
Nasdaq
Security
Ordinary Shares

Money raised, against the largest IPOs

  • Alibaba '14$21.77B
  • Facebook '12$18.41B
  • Rivian '21$11.93B
  • Uber '19$8.1B
  • Arm '23$5.23B
  • Electra Therapeutics$350M

Where ETRA ranks

Electra Therapeutics's market cap against the largest US-listed companies.

Market cap, against the largest US-listed companies

  • AAPL$5.12T
  • MSFT$3.77T
  • NVDA$3.65T
  • GOOGL$3.47T
  • AMZN$2.9T
  • TSM$1.88T
  • AVGO$1.69T
  • META$1.58T
  • TSLA$1.52T
  • BRK.B$1.22T
  • ETRA$529.13M

ETRA news

The latest news and headlines about Electra Therapeutics (ETRA).

Filings and the company

What Electra Therapeutics has disclosed to the SEC, and the basic facts about the listing.

8-K filings

Material events that Electra Therapeutics discloses to the SEC on Form 8-K.

  • Quarterly earningsNov 12, 2026

    On November 12, 2026, Electra Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.

  • Public offeringSep 21, 2026

    On September 21, 2026, the Company closed its IPO of an aggregate of 23,333,334 shares of common stock at a price to the public of $15.00 per share. The aggregate gross proceeds from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were approximately $350.0 million.

About Electra Therapeutics

Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's pipeline includes Ipsoprubart and ELA822.

Ticker
ETRA
Exchange
Nasdaq
Market
stocks
Type
CS
Currency
USD
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
Sep 18, 2026
Security
Ordinary Shares
Company website

Frequently asked questions

What was the Electra Therapeutics IPO price?

$15.00 a share.

When did Electra Therapeutics go public?

Electra Therapeutics listed on Nasdaq on Sep 18, 2026 under the ticker ETRA.

How much did the Electra Therapeutics IPO raise?

$350M, before any underwriters' option.

How did Electra Therapeutics open on its first day?

ETRA first traded at $15.00, +0.00% from the IPO price of $15.00.

How did ETRA close on its first day?

Its last regular-session trade was $13.51, -9.93% from the IPO price of $15.00.

What was the ETRA first-day trading range?

$13.31 to $15.50 in the regular session.

How many ETRA shares traded on the first day?

4.88M shares in the regular session.

How many shares did Electra Therapeutics sell in its IPO?

23.33M shares.

How did ETRA do against the market on its first day?

ETRA fell 9.9% from its first trade to the last trade of the session. That is 10.6 points worse than the market (QQQ, the Nasdaq-100 ETF).

What exchange is ETRA listed on?

Electra Therapeutics lists on Nasdaq under the ticker ETRA.

Build with Massive

Get the ETRA data behind this page

The Massive endpoint behind each section of this page
What the page showsEndpoint
Offering terms and dates/vX/reference/ipos
Price/v3/snapshot
Chart, VWAP, and the market comparison/v2/aggs/ticker/ETRA/range/5/minute
Market cap/v3/reference/tickers/ETRA
News/v2/reference/news
Filings/vX/disclosures

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.